GlassScriptPhysician profile
John M Miller
NPI 1467417022
$354,132.68
in general payments reported to CMS, 2019-2025
23 companies · $104K in 2025
The $104K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $9,513 · 2021: $7,060 · 2022: $27K · 2023: $66K · 2024: $94K · 2025: $104K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $152K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $59K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Travel and Lodging: $20K · Food and Beverage: $11K · Education: $94.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $151,720.08 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $58,575.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,725.00 |
| Travel and Lodging | $20,276.65 |
| Food and Beverage | $10,721.82 |
| Education | $94.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $107,468.62 | 2019-2025 | Acticor 7 Vr-T Dx, Plexa Promri, Pamira |
| Biosense Webster, INC. | $98,770.73 | 2019-2025 | Carto 3, Thermocool Sf, Soundstar |
| Medical Device Business Services, INC. | $66,665.22 | 2019-2024 | Carto 3 |
| Abbott Laboratories | $42,116.70 | 2019-2025 | Gallant, Aveir, Ensite |
| Boston Scientific Corporation | $18,103.56 | 2019-2025 | Farapulse, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $8,052.97 | 2022-2025 | Cobalt Dr Mri Surescan, Pulseselect, Attain Command + Surevalve |
| Medtronic Vascular, INC. | $6,691.53 | 2019 | |
| Vektor Medical INC. | $5,030.61 | 2024-2025 | Vmap |
| Cardiva Medical, INC. | $269.30 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Volta Medical INC | $257.53 | 2023-2024 | Vx1 |
| Regeneron Healthcare Solutions, INC. | $209.06 | 2025 | Dupixent |
| Biosig Technologies, INC. | $188.84 | 2019 | |
| Pfizer INC. | $59.68 | 2023-2024 | |
| Genzyme Corporation | $44.19 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $43.46 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36.31 | 2022-2024 | Xarelto |
| Lilly USA, LLC | $32.02 | 2022-2023 | Mounjaro |
| Amgen INC. | $18.17 | 2023 | Repatha |
| Axsome Therapeutics, INC. | $17.83 | 2025 | Auvelity |
| Ironshore Pharmaceuticals INC. | $14.72 | 2023 | Jornay Pm |
| Chiesi USA, INC. | $14.68 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.51 | 2024 | Camzyos |
| Arbor Pharmaceuticals, INC. | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.